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INTRODUCTION
Abnormal uterine bleeding (AUB) accounts for
20% of visits to the gynecologist. It is defined as
any variation of bleeding outside from normal
menstrual cycle that includes change in regularity,
frequency, duration of flow, and amount of blood
loss. Several common pathological conditions
causing abnormal vaginal bleeding are
leiomyomas, endometrial polyps, and adeno-
myosis. Other less frequent conditions are
endometritis and uterine cancers.1
Abstract
Objective: To investigate the accuracy of endometrial sampling in
the diagnosis of endometrial pathology and the need of intra-
operative frozen section.
Methods: One hundred forty women who underwent endometrial
sampling followed by hysterectomy between 2011 and 2014 were
included in this study. Data were retrieved from patient files and
pathology archives in Department of Obstetrics and Gynecology,
Jose R. Reyes Memorial Medical Center, Manila, Philippines.
Results: There were 25 patients with malignancy but endometrial
sampling detected only 22 of them. The endometrial sampling
sensitivity and specificity for detecting cancer were 88% and 100%,
respectively with negative and positive predictive values of 97.5%
and 100%, respectively. In 3 patients, the endometrial sampling
failed to detect malignancy; 1 patient had a preoperative diagnosis
of complex hyperplasia with atypia, 1 patient had complex
hyperplasia without atypia and 1 patient had adenofibroma. A total
of eighty patients had benign findings. There were fifty-three cases
with finding of proliferative endometrium and twenty-seven were
secretory. Twenty-three (55.0%) and 11 (39.0%) cases were
confirmed by the hysterectomy specimen, respectively. The
sensitivity of endometrial sampling in detecting benign samples was
76.0% and the specificity reached up to 83.0%. The histopathology
result of the other fourteen cases were reported of having atrophy,
twelve cases were reported of having endometrial hyperplasia, four
with basal endometrium, four with endometrial polyp and one with
adenomyosis.
Conclusion: Outpatient endometrial biopsy has a high overall
accuracy in diagnosing endometrial cancer when the specimen
obtained is sufficient. A positive test result is more accurate for
ruling in disease than a negative test result is for ruling it out.
However, the diagnosis should be confirmed by frozen section in
patients with complex hyperplasia and adenofibroma.
[Indones J Obstet Gynecol 2017; 5-1: 23-29]
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Abstrak
Tujuan: Untuk menyelidiki keakuratan pengambilan sampel
endometrium dalam mendiagnosis patologi endometrium dankebutuhan yang memerlukan teknik potong beku selama operasi.
Metode: Seratus empat puluh perempuan yang menjalanipengambilan sampel endometrium diikuti oleh histerektomi antara
2011-2014 dilibatkan dalam penelitian ini. Data diambil dari file
pasien dan arsip patologi.
Hasil: Terdapat 25 pasien dengan keganasan, namun endometriumsampel hanya mampu mendeteksi 22 dari mereka. Sensitivitas dan
spesifisitas dari pengambilan sampel endometrium mendeteksi kanker
adalah masing-masing 88% dan 100%, dengan nilai duga negatif danpositif masing-masing sebesar 97,5% dan 100%. Pada 3 pasien,
pengambilan sampel endometrium gagal mendeteksi keganasan; 1
pasien memiliki diagnosis preoperatif kompleks hiperplasia denganatipia, 1 pasien memiliki kompleks hiperplasia tanpa atipia dan 1
pasien memiliki adenofibroma. Sebanyak delapan puluh pasienmemiliki temuan jinak. Ada 53 kasus dengan temuan proliferasi
endometrium dan 27 yang sekretori. Masing-masing sebanyak 23
(55,0%) dan 11 (39,0%) dikonfirmasi oleh spesimen histerektomi.Sensitivitas sampling endometrium dalam mendeteksi sampel jinak
adalah 76,0% dan spesifisitas adalah 83,0%. Hasil histopatologi dari
14 kasus lain dilaporkan memiliki atrofi, 12 kasus dilaporkan memilikihiperplasia endometrium, 4 dengan basal endometrium, 4 memiliki
polip endometrium dan 1 memiliki adenomiosis.
Kesimpulan: Rawat jalan biopsi endometrium memiliki akurasi
keseluruhan tinggi dalam mendiagnosis kanker endometrium ketikaspesimen yang diperoleh sudah cukup. Hasil tes positif lebih akurat
untuk mendiagnosis suatu penyakit daripada suatu hasil tes negatif
untuk mengesampingkan suatu penyakit. Namun, diagnosis harusdikonfirmasi oleh potong beku pada pasien dengan kompleks
hiperplasia dan adenofibroma.
[Maj Obstet Ginekol Indones 2017; 5-1: 23-29]
Kata kunci: hiperplasia endometrium, perdarahan uterus abnormal,
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Endometrial pathology has been identified and
diagnosed using several methods. Endometrial
sampling has gained popularity as an alternative
diagnostic tool compared with more invasive
procedures, such as fractional dilatation and
curettage (D&C).2
The morphological appearance of atypical
endometrial hyperplasia and well-differentiated
endometrial carcinoma on biopsy specimen
presents a major challenge to pathologists.3 When
a Pipelle endometrial biopsy or curettage specimen
can be diagnosed as atypical hyperplasia, there is a
risk of concomitant invasive carcinoma in the
uterus. Seven to fifty percent (7-50%) of women
with endometrial hyperplasia with cytological
atypia were found to have concomitant carcinoma
in subsequent hysterectomy specimens.4 Exclusion
of cancer in an atypical hyperplasia finding on
biopsy is a difficult challenge for the gynecologist.
Hysterectomy is the most frequently performed
surgery in gynecology. When it performed for
benign indication, frozen section should still be kept
doing if there is suspicion of malignancy in the gross
specimen in spite of a negative preoperative biopsy.
Several studies had been performed to evaluate
the accuracy of endometrial biopsy in identifying
the cause of AUB and they showed variation of
results.5-7 According to this discrepancy, we
conducted this study to compare the accuracy of
preoperative endometrial sampling for the
detection of endometrial pathology with
postoperative hysterectomy specimen in local
settings.
METHODS
This was a retrospective cohort study design
involving chart review of patients who underwent
endometrial sampling and were treated with
hysterectomy in Department of Obstetrics and
Gynecology, Jose R. Reyes Memorial Medical Center,
Manila, Philippines from January 2011 to December
2014. Clinical and pathological information were
reviewed and obtained from patient charts to
complete the desired sample size for the study. All
collected data were recorded, encoded, and
presented in tables. We reviewed the charts of 140
patients who were qualified. Accuracy of
endometrial sampling and hysterectomy specimen
were determined by computing for the sensitivity,
specificity, PPV, and NPV for each diagnostic
modality by comparing the preoperative results
with the final histopathology findings.
Inclusion criteria included all women with AUB
and concomitant gynecological pathology who
underwent endometrial sampling and were treated
by hysterectomy within a year of the diagnosis.
Exclusion criteria were all women who presented
with AUB due to cervical pathology and patients
who underwent hysterectomy more than a year of
the diagnosis.
Review of charts, histopathological results of
endometrial sampling, and final histopathological
results were gathered from the medical records and
Pathology Department from January 2011 to
December 2014.
All the statistical tests were performed in SPSS
version 20.0. We considered the result significantly
if p-values less than 0.05.
RESULTS
A total of 140 women were included in the study,
with mean age of 47.9 years old (ranging from 28
to 70 years old) and mean gravidity of 2.8 (ranging
from 0 to 11). Forty-two (30.0%) were post-
menopausal women who were 50 years old or
older.
Myoma was the most common indication for
hysterectomy, as reported by 47 (33.6%) patients,
followed by AUB (n=33, 23.6%), and endometrial
carcinoma (n=22, 15.7%). Less common reasons
were post-menopausal bleeding (n=8, 5.7%) and
pelvic organ prolapse (n=1, 0.7%).
The preoperative results of endometrial
sampling and the final pathological diagnosis were
described on Table 1.
Table 1. Concordance Rate of Endometrial Biopsy and Hysterectomy Specimen Histopathology
Finding Pipelle BiopsyN (%) Hysterectomy SpecimenN (%) ConcordanceN (%)
Malignant
Adenocarcinoma 21 (15.0) 23 (16.4) 21 (15.0)
Malignant Mixed Müllerian Tumor (MMMT) 0 (0) 1 (0.7) 0 (0)
Serous Carcinoma 1 (0.7) 1 (0.7) 1 (0.7)
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Of the twenty-three (16.4%) cases confirmed to
have adenocarcinoma by hysterectomy specimen,
21 cases were correctly diagnosed by endometrial
biopsy. One case of serous carcinoma was also
correctly diagnosed by endometrial biopsy. One
case of Malignant Mixed Müllerian Tumor (MMMT)
was missed by endometrial biopsy.
For the benign cases, 53 (37.9%) cases were
read as proliferative endometrium in the final
specimen. Only 23 out of 42 cases were initially
diagnosed by endometrial biopsy matched the
result of hysterectomy specimen. Twenty-seven
(19.3%) were confirmed secretory cases, but only
11 out of 28 cases were initially diagnosed
secretory cases as confirmed by hysterectomy
specimen. None of the proliferative and secretory
reading by endometrial biopsy were interpreted as
cancer on the final hysterectomy specimen.
Two cases of complex hyperplasia with atypia
were diagnosed by endometrial biopsy, which on
hysterectomy specimen was found to have
proliferative endometrium and adenocarcinoma.
Two cases of complex hyperplasia without atypia
were diagnosed by endometrial biopsy; however,
they were not confirmed at hysterectomy. One of
them turned out to be simple hyperplasia on
hysterectomy specimen and the other one was
adenocarcinoma. Another case was accurately
diagnosed as simple hyperplasia both by sampling
and hysterectomy specimen. One case of simple
hyperplasia with atypia was initially diagnosed by
endometrial biopsy; it was confirmed by
hysterectomy section yet. Of the 15 cases of simple
hyperplasia without atypia diagnosed by
endometrial biopsy, four cases were confirmed by
hysterectomy section. There were other six cases
of simple hyperplasia without atypia as reported
by hysterectomy specimen which endometrial
biopsy failed to diagnose initially.
There were 71 patients with benign endometrial
pathologies diagnosed by endometrial biopsy, but
only 61 (85.9%) cases were confirmed by
hysterectomy specimen results. Hysterectomy
specimen showed that among those 10 patients,
five had atrophy, two had simple hyperplasia
without atypia, one had endometrial polyp, one
had basal endometrium, and one had simple
hyperplasia with atypia.
All the 22 patients with malignancy diagnosed
by endometrial biopsy remained the same by final
pathology. Endometrial biopsy failed to diagnose
the other three cases of malignancy. Complex
hyperplasia with and without atypia were the
biopsy diagnoses of the two adenocarcinoma cases;
while, adenofibroma was the initial diagnosis of the
patient with MMMT.
Finding Pipelle BiopsyN (%) Hysterectomy SpecimenN (%) ConcordanceN (%)
Benign
Proliferative 42 (30.0) 53 (37.9) 23 (16.4)
Secretory 28 (20) 27 (19.3) 11 (7.9)
Endometrial hyperplasia
Complex hyperplasia with atypia 2 (1.4) 1 (0.7) 0 (0)
Complex hyperplasia without atypia 2 (1.4) 0 (0) 0 (0)
Simple hyperplasia with atypia 1 (0.7) 1 (0.7) 0 (0)
Simple hyperplasia without atypia 15 (10.7) 10 (7.1) 4 (2.9)
Adenofibroma 1 (0.7) 0 (0) 0 (0)
Adenomyosis 1 (0.7) 1 (0.7) 1 (0.7)
Atrophic 12 (8.6) 14 (10) 6 (4.3)
Basal Endometrium 1 (0.7) 4 (2.9) 1 (0.7)
Endometrial polyp 5 (3.6) 4 (2.9) 1 (0.7)
Tissue Insufficiency 8 (5.7) 0 (0) 0 (0)
Vol 5, No 1
January 2017 Accuracy of preoperative endometrial sampling  25
The endometrial sampling sensitivity and
specificity of detecting malignant cancer were
88.0% [22/25] and 100.0% [115/115], with
negative and positive predictive values of 100.0%
[22/22], and 97.5% [115/118], respectively
(Table 2).
On the remaining 47 patients that biopsy failed
to detect as malignancy or benign pathologies,
three cases were confirmed to be malignancy (two
adenocarcinoma cases and one case of MMMT), 19
confirmed with benign cases (17 proliferative and
two secretory), and 25 others (nine cases of
atrophy, eight cases of simple hyperplasia without
atypia, three cases of basal endometrium, three
cases of endometrial  polyp, one case of
adenomyosis, and one case of complex hyperplasia
with atypia).
Pipelle biopsy had a very good agreement
[K=0.923, p<0.001] in the diagnosis of malignant
cancer. Specifically, it had very good agreement
[K=0.946, p<0.001] in diagnosis of adenocarcinoma
with sensitivity and specificity of 91.3% and
100.0%, respectively, with positive predictive
value of 100.0% and negative predictive value of
98.3%. It also had very good agreement [K=1.000,
p<0.001] in diagnosis of serous carcinoma with
sensitivity, specificity, positive predictive value and
negative predictive value of 100.0% for all results.
However, it had poor agreement [K=0.000,
p=1.000] in the diagnosis of MMMT in 1 patient,
which the endometrial sampling failed to detect
malignancy of adenofibroma on a 64-year old
woman with postmenopausal bleeding.
Table 2. Kappa, Sensitivity, Specificity, Positive Predictive Value, Negative Predictive Value of Endometrial Biopsy
Compared with Hysterectomy Specimen
Findings N (%) Kappa Sensitivity Specificity PPV NPV
Malignant 25 (17.9) 0.923* 22/25 (88.0%) 115/115 (100.0%) 22/22 (100.0%) 115/118 (97.5%)
Adenocarcinoma 23 (16.4) 0.946* 21/23 (91.3%) 117/117 (100.0%) 21/21 (100.0%) 117/119 (98.3%)
Malignant Mixed
Müllerian Tumor
(MMMT)
1 (0.7) 0.000 0/1 (0%) 139/139 (100.0%) 0/0 139/140 (99.3%)
Serous carcinoma 1 (0.7) 1.000* 1/1 (100.0%) 139/139 (100.0%) 1/1 (100.0%) 139/139 (100.0%)
Benign 80 (57.1) 0.585* 61/80 (76.3%) 50/60 (83.3%) 61/71 (85.9%) 50/69 (72.5%)
Proliferative 53 (37.9) 0.225* 23/53 (43.4%) 68/87 (78.2%) 23/42 (54.8%) 68/98 (69.4%)
Secretory 27 (19.3) 0.253* 11/27 (40.7%) 96/113 (85%) 11/28 (39.3%) 96/112 (85.7%)
Others 35 (25.0)
Endometrial
hyperplasia
12 (8.6) 0.370* 7/12 (58.3%) 115/128 (89.8%) 7/20 (35.0%) 115/120 (95.8%)
Complex hyperplasia
with atypia
1 (0.7) -0.010 0/1 (0%) 137/139 (98.6%) 0/2 (0%) 137/138 (99.3%)
Complex hyperplasia
without atypia
0 (0) 0.000 0/0 138/140 (98.6%) 0/2 (0%) 138/138 (100.0%)
Simple hyperplasia
with atypia
1 (0.7) -0.007 0/1 (0%) 138/139 (99.3%) 0/1 (0%) 138/139 (99.3%)
Simple hyperplasia
without atypia
10 (7.1) 0.256* 4/10 (40.0%) 119/130 (91.5%) 4/15 (26.7%) 119/125 (95.2%)
Adenofibroma 0 (0) 0.000 0/0 139/140 (99.3%) 0/1 (0%) 139/139 (100.0%)
Adenomyosis 1 (0.7) 1.000* 1/1 (100.0%) 139/139 (100.0%) 1/1 (100.0%) 139/139 (100.0%)
Atrophic 14 (10) 0.407* 6/14 (42.9%) 120/126 (95.2%) 6/12 (50.0%) 120/128 (93.8%)
Basal endometrium 4 (2.9) 0.393* 1/4 (25.0%) 136/136 (100%) 1/1 (100.0%) 136/139 (97.8%)
Endometrial polyp 4 (2.9) 0.179* 1/4 (25.0%) 132/136 (97.1%) 1/5 (20.0%) 132/135 (97.8%)
Tissue insufficiency 0 (0) 0.000 0/0 132/140 (94.3%) 0/8 (0%) 132/132 (100.0%)
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For benign samples, Pipelle biopsy had
moderate agreement [K=0.585, p<0.001] with
hysterectomy specimen results, having sensitivity
and specificity of 76.3% and 83.3%, respectively.
Specifically, proliferative [K=0.225, p=0.007] and
secretory [K=0.253, p=0.003] of benign cases had
fair agreement with hysterectomy specimen
results.
Other findings showed that Pipelle biopsy had
fair agreement in diagnosing atrophy [K=0.407,
p<0.001], basal endometrium [K=0.393, p<0.001];
however, it described poor agreement in the
diagnosis of endometrial polyp [K=0.179, p<0.019].
Among the endometrial hyperplasia, Pipelle biopsy
showed significant agreement [K=0.256, p=0.002]
with hysterectomy specimen results only in the
diagnosis of simple hyperplasia without atypia. The
Pipelle biopsy showed no significant agreement
with hysterectomy specimen results in the
diagnosis of other endometrial hyperplasia, such as
simple hyperplasia with atypia [K=-0.007, p=0.932],
complex hyperplasia with atypia [K=-0.010,
p=0.904] and complex hyperplasia without atypia
[K=0.000, p=1.000]. Likewise, the Pipelle biopsy
showed no significant agreement with hysterec-
tomy specimen results in the diagnosis of
adenofibroma [K=0.000, p=1.000] and tissue
insufficiency [K=0.000, p=1.000].
Twenty patients diagnosed with endometrial
hyperplasia through Pipelle biopsy were confirmed
to have endometrial hyperplasia only in seven
patients, leading to PPV of 35.0%. The remaining
13 patients were confirmed to have proliferative
(n=8), adenocarcinoma (n=2), basal endometrium
(n=1) and secretory (n=2). All descriptions were
shown on Table 3.
Eight specimens were found to have tissue
adequacy. Gravidity (p=0.127) and menopausal
status (p=0.299) did not determine sample
adequacy of Pipelle biopsy.
Table 3. Confirmation of Hysterectomy Specimen in Patients with Initial Endometrial Hyperplasia through
Endometrial Biopsy
Case
Age
(years old) Indication Pipelle Biopsy Hysterectomy specimen
1 57 Endometrial hyperplasia Complex hyperplasia with atypia Adenocarcinoma
2 47 Endometrial hyperplasia Complex hyperplasia with atypia Proliferative
3 51 Endometrial hyperplasia Complex hyperplasia without atypia Simple hyperplasia without atypia
4 49 Endometrial hyperplasia Complex hyperplasia without atypia Adenocarcinoma
5 47 Endometrial hyperplasia Simple hyperplasia with atypia Simple hyperplasia without atypia
6 44 Endometrial hyperplasia Simple hyperplasia without atypia Secretory
7 52 Endometrial hyperplasia Simple hyperplasia without atypia Secretory
8 43 AUB Simple hyperplasia without atypia Proliferative
9 44 AUB Simple hyperplasia without atypia Proliferative
10 47 Endometrial hyperplasia Simple hyperplasia without atypia Proliferative
11 65 Ovarian Cyst Simple hyperplasia without atypia Proliferative
12 50 Endometrial hyperplasia Simple hyperplasia without atypia Proliferative
13 40 Myoma Simple hyperplasia without atypia Proliferative
14 40 Endometrial hyperplasia Simple hyperplasia without atypia Proliferative
15 55 Endometrial hyperplasia Simple hyperplasia without atypia Complex hyperplasia with atypia
16 48 AUB Simple hyperplasia without atypia Basal endometrium
17 39 Endometrial hyperplasia Simple hyperplasia without atypia Simple hyperplasia without atypia
18 51 Endometrial hyperplasia Simple hyperplasia without atypia Simple hyperplasia without atypia
19 45 Endometrial hyperplasia Simple hyperplasia without atypia Simple hyperplasia without atypia
20 44 Endometrial hyperplasia Simple hyperplasia without atypia Simple hyperplasia without atypia
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DISCUSSION
Abnormal uterine bleeding has been the most
common complaint of women during reproductive
years and post-menopausal life. There are various
benign reasons for AUB. However, uterine bleeding
is the most common sign of endometrial cancer.
Endometrial sampling with Pipelle is cost
effective and a safe procedure; it is widely used in
the investigation of perimenopausal and post-
menopausal women with AUB. We take only a few
minutes to perform the procedure with Pipelle so
that it is the most convenient and best tolerated.
Besides, this procedure causes less pain.8 In a local
study by L. Co, et al. in 2000, Pipelle endometrial
biopsy instrument was an effective office device for
evaluating patients with AUB because it was
associated with less pain, better specimen yield
with similar histologic findings (100%) as the
standard curettage.9 Another study by Mochtar, et
al. also had similar conclusion that the operating
time and the percentage of patients who reported
tachycardia and pain were significantly higher in
Novak curette group compared with the Manual
Vacuum Aspiration.10
Discrepancy  was  found between the
histopathological result of endometrial samples
and the hysterectomy specimens. In our study,
patient who had discrepancy between the
histopathological result of endometrial samples
and the hysterectomy specimens, underwent
intraoperative frozen section and were treated
with complete surgical staging.
Pathologists are dealing with increasing number
of endometrial specimens in which there is scant,
or even absent endometrial tissue, especially when
the endometrium is atrophic. These specimens
may consist entirely of superficial strips or wisps
of atrophic glands, with little or no stroma,
admixed with cervical mucus, ectocervical or endo-
cervical tissue, and tissue from the lower uterine
segment. In published studies, inadequate rates of
outpatient endometrial biopsies were ranged from
4.8 to 33%; although, in most of these studies, the
criteria for adequacy was not clearly mentioned.11
Routine criteria for adequacy of endometrial
biopsies was applied by the pathologist consultant
in the routine biopsy. Adequacy of the preparation
was assessed as satisfactory when sufficient
endometrial material (endometrial glands and
stroma) was presented to make a pathological
diagnosis or to exclude a pathological process. A
specimen was assessed as inadequate if there was
insufficient endometrial material in the cell block
to exclude a pathological diagnosis. The pathologist
recorded the quality of the biopsy sample and
provided a diagnosis if the sample was sufficient.9
Our study result showed that outpatient
endometrial biopsy was an accurate diagnostic
procedure when adequate specimens were
obtained, it had high overall accuracy in diagnosing
endometrial  cancer.  As the diagnosis of
endometrial cancer was very important, the
likelihood ratio for a positive test should raise most
pre-test probabilities over any threshold for
advanced management. In contrast, the likelihood
ratio for a negative test was not low enough to
negate the need for further diagnostic testing.
Three endometrial cancers were missed among
adequate biopsy specimens.  Inadequate
endometrial samples might come from poor biopsy
technique, inherent problems with non-
representative sampling, varied pathological
interpretation or be consistent with the underlying
atrophic endometrial state.
In our study, both inadequate samples on Pipelle
were benign lesions and no case of endometrial
carcinoma was missed. Our study had shown low
sensitivity (76.3%) but high specificity (83.3%) for
Pipelle in diagnosing benign diseases. However,
malignant diseases had a sensitivity and specificity
of 88.0% and 100.0%; respectively. This led to the
conclusion that the Pipelle was superior for
diagnosing malignant disease and hyperplasia as
compared with benign diseases. This finding was
reported in a study by Clark et al in 2002.5
A finding which was also reported in a study by
Festin MR, et al .  in 2006, concluded that
endometrial biopsy was a useful diagnostic
procedure for the detection of endometrial
abnormalities with accuracy of biopsy of 91.5% in
patients underwent hysterectomy and was
comparable to endometrial curettage with
accuracy of 92.3%.12
CONCLUSION
The endometrial biopsy is found to be accurate,
easy, and safe. However, inconsistency is found
between the histopathological results of specimens
obtained by endometrial  sampling and
hysterectomy specimens.
Indones J
28  Tali and Cole Obstet Gynecol
The disadvantages of a Pipelle biopsy are that
often only very scant tissue is obtained, especially
in a postmenopausal woman with an atrophic
endometrium, and focal lesions may be missed.
Furthermore, the frequent association between
atypical hyperplasia and carcinoma means that
when a diagnosis of atypical hyperplasia is made,
irrespective of the sampling method, the clinician
must be concerned that endometrial carcinoma
exists concomitantly within the uterus.
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